Skip to main content

Top Bar Menu

Go to LUNGevity.org › Sign Up For Emails

  • Non-Small Cell Lung Cancer
    • NSCLC
    • ALK
    • EGFR
    • KRAS
    • Rare Mutations
  • Small Cell Lung Cancer
  • Resources
    • Clinical Trials
    • Find a Cancer Center
    • Resource Library
    • Podcast

Go to LUNGevity.org › Sign Up For Emails

Patient Gateways

Top Bar Menu

Go to LUNGevity.org › Sign Up For Emails

  • Non-Small Cell Lung Cancer
    • NSCLC
    • ALK
    • EGFR
    • KRAS
    • Rare Mutations
  • Small Cell Lung Cancer
  • Resources
    • Clinical Trials
    • Find a Cancer Center
    • Resource Library
    • Podcast

Main navigation

Close Menu
  • Clinical Trials
  • Clinical Trials
  • Clinical Trials
  • Clinical Trials
  • Clinical Trials
  • Clinical Trials

You are about to leave the Patient Gateway

You’re one click away from learning about one of our most valued sponsors. Read about how they’re making a difference in patients’ lives.

ProceedCancel

Patient Gateway

RSS Feed

  • NSCLC Feed
  • ALK Feed
  • EGFR Feed
  • KRAS Feed
  • Rare Mutations Feed
  • SCLC Feed
Findings on Lung Cancer Reported by Investigators at Jilin University (Ncapg Reprograms Glycolytic and Lipid Metabolism By Sustaining Glycerophospholipid Flux In Small-cell Lung Cancer)

Researchers from Capital Medical University Report Details of New Studies and Findings in the Area of Lung Cancer (Proteomic Analysis of Urinary Exosomal S100 Proteins...

GSK's Licensor Hansoh Pharma Announces Positive Results From a Second Phase III Trial for Ris-Rez in China

AQP4-IgG-positive myelitis occurring in a patient with small cell lung cancer: a case report

A B7-H3 Antibody Drug Conjugate Just Won a Second Phase 3, in a Second Tumour

Markey Cancer Center treats first patient in U.S. with new lung cancer therapy

Real-World Analysis Identifies Performance Status as a Key Predictor of Outcomes With Tarlatamab in Extensive-Stage Small Cell Lung Cancer

Clinical Trial: A Single-arm, Exploratory Clinical Study Evaluating the Efficacy and Safety of Bevacizumab in Combination With Anlotinib and Etoposide as First-line Therapy for Elderly...

Izalontamab Brengitecan Shows Promising Clinical Activity in Previously Treated Extensive-Stage Small Cell Lung Cancer

GSK PLC - Hansoh positive 2nd Phase III results for Riz-Rez

SHARE

The Patient Gateways are a project of LUNGevity Foundation, an organization transforming how people are diagnosed and live with lung cancer. Learn more here.

Privacy policy | Contact us

 

This website is not intended to, and does not, provide medical advice, professional diagnosis, opinion, treatment, or services. Medical information provided on this site is for informational and educational purposes only. After reading content from this website, you are encouraged to review the information carefully with your physician.

 

Copyright © 2026 LUNGevity Foundation. All rights reserved.